No full-text available
To read the full-text of this research,
you can request a copy directly from the authors.
No effect of activated charcoal on hyperlipidaemia. A double-blind prospetive trial
Abstract
The lipid-lowering effect of activated charcoal was studied during a placebo-controlled double-blind prospective trial in 19, mainly hyperlipidaemic patients. Dosages of 15 and 30 g of activated charcoal per day were prescribed for 12-wk periods. Mean serum cholesterol levels ± SD in patients treated with 15 and 30 g of activated charcoal did not decrease significantly (10.2 ± 2.2 to 9.7 ± 2.7 and 10.5 ± 1.5 to 9.7 ± 1.6, respectively). In both the 15- and the 30-g activated charcoal groups, one patient had a significant decrease in serum cholesterol level. No decrease in serum triglycerides was observed in three hypertriglyceridaemic patients. We conclude that activated charcoal in a dosage of 15 or 30 g per day is ineffective in lowering serum cholesterol and triglyceride levels in patients with hyperlipidaemia.
Herbal medicines are regulated in many countries and accepted to be integrated in healthcare system. Herbal medicine is an affordable health care resource for many countries. Among the World Health Organization (WHO) efforts for promoting the use of alternative medicines is the creation of awareness about safe and effective alternative medicine therapies among the public and consumers. For cardiovascular diseases, herbal treatments have been used in patients with atherosclerosis, (which occurs when fatty deposits clog and harden arteries), coronary heart disease, (caused by the reduced blood supply to the heart muscle), stroke, (caused by inadequate blood flow to the brain leading to the death of brain cells), hypertension, (occurs when blood pressure is higher than the normal range), cardiac arrhythmias, (which are irregular or abnormal heartbeats).
ResearchGate has not been able to resolve any references for this publication.